SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Clinical trial NCT04287179 · WITHDRAWN
Trial details
- NCT number
- NCT04287179
- Sponsor
- Novo Nordisk A/S
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2020-11-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.